Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife. This report contains market size and forecasts of Vesicular Stomatitis (VS) Therapeutics in Global, including the following market information: Global Vesicular Stomatitis (VS) Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Vesicular Stomatitis (VS) Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Symptomatic Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Vesicular Stomatitis (VS) Therapeutics include Boehringer Ingelheim, Merck & Co, Zoetis, Vedco, Elanco, Ceva Sant� Animale, Vibrac, Vetoquinol and IDEXX Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vesicular Stomatitis (VS) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Vesicular Stomatitis (VS) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Vesicular Stomatitis (VS) Therapeutics Market Segment Percentages, by Type, 2021 (%) Symptomatic Medications Vaccination Global Vesicular Stomatitis (VS) Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Vesicular Stomatitis (VS) Therapeutics Market Segment Percentages, by Application, 2021 (%) Veterinary Hospitals Veterinary Clinics Retail Pharmacies Global Vesicular Stomatitis (VS) Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Vesicular Stomatitis (VS) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Vesicular Stomatitis (VS) Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Vesicular Stomatitis (VS) Therapeutics revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Boehringer Ingelheim Merck & Co Zoetis Vedco Elanco Ceva Sant� Animale Vibrac Vetoquinol IDEXX Laboratories Covetrus Neogen
1 Introduction to Research & Analysis Reports 1.1 Vesicular Stomatitis (VS) Therapeutics Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Vesicular Stomatitis (VS) Therapeutics Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology
